-
平臺編號：bio-103870
-
細(xì)胞信息： FTC-238
-
規(guī)格：1×10?cells/T25培養(yǎng)瓶
-
用途：/
-
服務(wù)費(fèi)用：
加載中…… - 訂購
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
人類濾泡狀甲狀腺癌細(xì)胞FTC-238
FTC-238人類濾泡狀甲狀腺癌細(xì)胞，肺轉(zhuǎn)移
產(chǎn)品類別：人源細(xì)胞系
生長特性：Adherent
細(xì)胞形態(tài)：Polymorphic
凍存條件：90%FBS+10%DMSO
FTC-238人類濾泡狀甲狀腺癌細(xì)胞，肺轉(zhuǎn)移簡介
Synonyms: FTC-238
Background: FTC-238 was established from a lung metastasis of a follicular thyroid carcinoma from a 42-year-old male. The cells are polymorphic showing flat polygonal to spindle-like morphologies. Complex chromosomal changes were detected as well as a p53 mutation.
FTC-133 (ECACC Catalogue number 94060901), FTC-236 (ECACC Catalogue number 06030202) and FTC-238 (ECACC Catalogue number 94060902) were all derived from the same individual, a 42 year old male with follicular thyroid cancer. This has been confirmed by short tandem repeat STR-PCR analysis at ECACC The Y chromosome could not be detected in these cell line by (STR)-PCR analysis. It is a known phenomenon that due to the increased genetic instability of cancer cell lines the Y chromosome can be rearranged or lost resulting in lack of detection. The cell lines are identical to the source provided by the depositor based on the STR-PCR analysis.
Species: human (Homo sapiens)
Tissue: Thyroid (lung metastasis)
Disease: Human follicular thyroid carcinoma, lung metastasis
Gender: 42-year-old male
Morphology: Polymorphic
Growth Mode: Adherent
Doubling Time: N/A
DNA Profile: Amelogenin: X
CSF1PO: 10,11
D13S317: 11
D16S539: 11,12
D5S818: 11,12
D7S820: 9,10
THO1: 9.3
TPOX: 9
vWA: 15,18
Cell Line Authentication Service
Culture Medium: DMEM：Ham's F12(1:1)+ 5％FBS
We strongly suggest to purchase the complete medium
Cryopreservation medium: 90%FBS+10%DMSO
Karyotype: Not specified
Subculture Routine: Split sub-confluent cultures (70-80%) 1:10 to 1:20 i.e. seeding at 1-4x10,000 cells/cm2 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37°C.
